Literature DB >> 19631718

Spinal ceramide and neuronal apoptosis in morphine antinociceptive tolerance.

Leesa Bryant1, Tim Doyle, Zhoumo Chen, Salvatore Cuzzocrea, Emanuela Masini, M Cristina Vinci, Emanuela Esposito, Emanuela Mazzon, Daniela Nicoleta Petrusca, Irina Petrache, Daniela Salvemini.   

Abstract

Opiates, like morphine, are the most effective analgesics for treating acute and chronic severe pain, but their use is limited by the development of analgesic tolerance and hypersensitivity to innocuous and noxious stimuli. Because opioids are a mainstay of pain management, restoring their efficacy has great clinical importance. We have recently demonstrated that spinal ceramide, a sphingolipid signaling molecule plays a central role in the development of morphine antinociceptive tolerance. We now report that ceramide upregulation in dorsal horn tissues in response to chronic morphine administration is associated with significant neuronal apoptosis. Inhibition of ceramide biosynthesis attenuated both the increase in neuronal apoptosis and the development of antinociceptive tolerance. These findings indicate that spinal ceramide upregulation is a key pro-apoptotic event that occurs upstream of the development of morphine antinociceptive tolerance and support the rationale for development of inhibitors of ceramide biosynthesis as adjuncts to opiates for the management of chronic pain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631718      PMCID: PMC2754041          DOI: 10.1016/j.neulet.2009.07.051

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  40 in total

Review 1.  Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions.

Authors:  D J Mayer; J Mao; J Holt; D D Price
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Annemarie Ledeboer; Julie Wieseler-Frank; Erin D Milligan; Steven F Maier
Journal:  Brain Behav Immun       Date:  2006-12-18       Impact factor: 7.217

Review 3.  Inhibitors of sphingolipid metabolism enzymes.

Authors:  Antonio Delgado; Josefina Casas; Amadeu Llebaria; José Luís Abad; Gemma Fabrias
Journal:  Biochim Biophys Acta       Date:  2006-09-01

4.  Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice.

Authors:  Irina Petrache; Viswanathan Natarajan; Lijie Zhen; Terry R Medler; Amy T Richter; Chung Cho; Walter C Hubbard; Evgeny V Berdyshev; Rubin M Tuder
Journal:  Nat Med       Date:  2005-04-24       Impact factor: 53.440

5.  BAX translocation is a critical event in neuronal apoptosis: regulation by neuroprotectants, BCL-2, and caspases.

Authors:  G V Putcha; M Deshmukh; E M Johnson
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

6.  Activity of adenylyl cyclase and protein kinase A contributes to morphine-induced spinal apoptosis.

Authors:  Grewo Lim; Shuxing Wang; Jeong-Ae Lim; Jianren Mao
Journal:  Neurosci Lett       Date:  2005-12-02       Impact factor: 3.046

7.  Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways.

Authors:  Ines Batinić-Haberle; Michael M Ndengele; Salvatore Cuzzocrea; Júlio S Rebouças; Ivan Spasojević; Daniela Salvemini
Journal:  Free Radic Biol Med       Date:  2008-10-17       Impact factor: 7.376

8.  Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Michael M Ndengele; Vincenzo Mollace; Frank Porreca; Francesca Fabrizi; Emanuela Esposito; Emanuela Masini; George M Matuschak; Daniela Salvemini
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

9.  Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramide.

Authors:  Irina Petrache; Terry R Medler; Amy T Richter; Krzysztof Kamocki; Ugonma Chukwueke; Lijie Zhen; Yuan Gu; Jeremy Adamowicz; Kelly S Schweitzer; Walter C Hubbard; Evgeny V Berdyshev; Giuseppe Lungarella; Rubin M Tuder
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-04-25       Impact factor: 5.464

10.  Ceramide: a key signaling molecule in a Guinea pig model of allergic asthmatic response and airway inflammation.

Authors:  Emanuela Masini; Lucia Giannini; Silvia Nistri; Lorenzo Cinci; Rosanna Mastroianni; Wei Xu; Suzy A A Comhair; Dechun Li; Salvatore Cuzzocrea; George M Matuschak; Daniela Salvemini
Journal:  J Pharmacol Exp Ther       Date:  2007-11-27       Impact factor: 4.030

View more
  11 in total

1.  Cyclooxygenase-2 and inflammation mediators have a crucial role in reflux-related esophageal histological changes and Barrett's esophagus.

Authors:  Antonio Taddei; Valentina Fabbroni; Alessandro Pini; Laura Lucarini; Maria Novella Ringressi; Ornella Fantappiè; Daniele Bani; Luca Messerini; Emanuela Masini; Paolo Bechi
Journal:  Dig Dis Sci       Date:  2013-12-20       Impact factor: 3.199

2.  Contribution of acid sphingomyelinase in the periaqueductal gray region to morphine-induced analgesia in mice.

Authors:  Joseph K Ritter; Youwen Fang; Min Xia; Pin-Lan Li; William L Dewey
Journal:  Neuroreport       Date:  2012-09-12       Impact factor: 1.837

3.  Sphingosine-1-phosphate acting via the S1P₁ receptor is a downstream signaling pathway in ceramide-induced hyperalgesia.

Authors:  Tim Doyle; Zhoumou Chen; Lina M Obeid; Daniela Salvemini
Journal:  Neurosci Lett       Date:  2011-05-13       Impact factor: 3.046

Review 4.  The role of sphingolipids in psychoactive drug use and addiction.

Authors:  Liubov S Kalinichenko; Erich Gulbins; Johannes Kornhuber; Christian P Müller
Journal:  J Neural Transm (Vienna)       Date:  2018-01-10       Impact factor: 3.575

5.  Intraplantar-injected ceramide in rats induces hyperalgesia through an NF-κB- and p38 kinase-dependent cyclooxygenase 2/prostaglandin E2 pathway.

Authors:  Tim Doyle; Zhoumou Chen; Carolina Muscoli; Lina M Obeid; Daniela Salvemini
Journal:  FASEB J       Date:  2011-05-06       Impact factor: 5.191

6.  Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids.

Authors:  Carolina Muscoli; Tim Doyle; Concetta Dagostino; Leesa Bryant; Zhoumou Chen; Linda R Watkins; Jan Ryerse; Erhard Bieberich; William Neumman; Daniela Salvemini
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

7.  Morphine-induced apoptosis in the ventral tegmental area and hippocampus after the development but not extinction of reward-related behaviors in rats.

Authors:  Yasaman Razavi; Shabnam Zeighamy Alamdary; Seyedeh-Najmeh Katebi; Fariba Khodagholi; Abbas Haghparast
Journal:  Cell Mol Neurobiol       Date:  2013-11-27       Impact factor: 5.046

8.  Satureja khuzestanica prevents the development of morphine analgesic tolerance through suppression of spinal glial cell activation in rats.

Authors:  Saeed Esmaeili-Mahani; Bahareh Ebrahimi; Mehdi Abbasnejad; Bahram Rasoulian; Vahid Sheibani
Journal:  J Nat Med       Date:  2013-08-14       Impact factor: 2.343

9.  Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism.

Authors:  Amanda Finley; Zhoumou Chen; Emanuela Esposito; Salvatore Cuzzocrea; Roger Sabbadini; Daniela Salvemini
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

10.  Activation of peripheral KCNQ channels attenuates inflammatory pain.

Authors:  Hiroki Hayashi; Masashi Iwata; Noboru Tsuchimori; Tatsumi Matsumoto
Journal:  Mol Pain       Date:  2014-02-21       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.